Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
Andrea Ghelli Luserna di Rorà(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giovanni Martinelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 27
Related Papers
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
|Blood Cancer Journal|2015|119
IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia
|PLoS ONE|2012|89
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
|Leukemia|2017|38
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
|Cell Biology and Toxicology|2021|26